Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen

MicrobiologyOpen
John Osei Sekyere

Abstract

From 2009, Candida auris has emerged as a multidrug-resistant ascomycete yeast pathogen with the capacity for easy transmission between patients and hospitals, as well as persistence on environmental surfaces. Its association with high mortalities, breakthrough and persistent candidaemia, inconsistencies in susceptibility testing results, misidentification by available commercial identification systems and treatment failure, complicates its management and detection. Within the last nine years, C. auris has been increasingly reported from far-Eastern Asia, the Middle East, Africa, Europe, South and North America with substantial fatalities and misidentification. Herein, I provide a systematic and thorough review of this emerging pathogen. Meta-analysis showed that at least 742 C. auris isolates have been reported in 16 countries, with most of these being from India (≥243), USA (≥232) and UK (≥103) (p-value = .0355) within 2013-2017. Most isolates were from males (64.76%) (p-value = .0329) and blood (67.48%) (p-value < .0001), with substantial crude mortality (29.75%) (p-value = .0488). Affected patients presented with other comorbidities: diabetes (≥52), sepsis (≥48), lung diseases (≥39), kidney diseases (≥32) etc. (p-value < .0...Continue Reading

References

Feb 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mi-Na KimDong Wook Ryang
Jul 1, 2011·Journal of Clinical Microbiology·Wee Gyo LeeHee-Chang Jang
Mar 20, 2013·Indian Journal of Medical Microbiology·S SarmaA Rattan
Sep 21, 2013·Emerging Infectious Diseases·Anuradha ChowdharyJacques F Meis
Dec 21, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A ChowdharyJ F Meis
Dec 24, 2013·Médecine et maladies infectieuses·P Nordmann
Jun 26, 2014·Emerging Infectious Diseases·Rindidzani E MagoboNelesh P Govender
Aug 16, 2014·International Journal of Antimicrobial Agents·Salome N SeiffertAndrea Endimiani
Dec 17, 2014·Intensive Care Medicine·Arunaloke ChakrabartiDeepak Mendiratta
Feb 7, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A K GhoshA Chakrabarti
Apr 18, 2015·Journal of Infection in Developing Countries·Dharmendra KumarRagini Tilak
May 20, 2015·Emerging Infectious Diseases·Maha EmaraRitu Bafna
Aug 8, 2015·Journal of Applied Microbiology·J Osei SekyereS Y Essack
Sep 9, 2015·BMC Genomics·Sharanya ChatterjeeUtpal S Tatu
Nov 10, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Anupam PrakashAnuradha Chowdhary
May 19, 2016·Emerging Infectious Diseases·Patrice NordmannLaurent Poirel
Jul 28, 2016·The Journal of Infection·Belinda CalvoArnaldo Lopes Colombo
Aug 2, 2016·Lancet·Ramanan LaxminarayanJohn-Arne Røttingen
Oct 8, 2016·Journal of Microbiology and Biotechnology·Tae-Hyoung KimMi-Kyung Lee
Oct 26, 2016·Antimicrobial Resistance and Infection Control·Silke SchelenzMatthew C Fisher
Nov 25, 2016·Journal of Clinical Microbiology·Masako MizusawaSean X Zhang
Dec 17, 2016·Emerging Infectious Diseases·Soraya E Morales-LópezJosé Y Rodríguez
Dec 18, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C WattalS Khanna
Dec 19, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shawn R LockhartAnastasia P Litvintseva
Jan 19, 2017·Emerging Infectious Diseases·Ronen Ben-AmiTalya Finn
Jan 19, 2017·Emerging Infectious Diseases·Leighann SherryRiina Rautemaa-Richardson
Jan 31, 2017·Revista iberoamericana de micología·Alba Cecilia Ruiz GaitánJavier Pemán
Feb 17, 2017·Medical Mycology·Andrew M BormanElizabeth M Johnson
Mar 24, 2017·The Journal of Antimicrobial Chemotherapy·Shivaprakash M RudramurthyAnup Ghosh
Mar 24, 2017·The American Journal of Nursing·Betsy Todd
May 10, 2017·Antimicrobial Agents and Chemotherapy·Elizabeth L BerkowShawn R Lockhart
May 19, 2017·MMWR. Morbidity and Mortality Weekly Report·Sharon TsayBrendan R Jackson
May 19, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marwan M AzarVirginia M Pierce
May 26, 2017·Journal of Clinical Microbiology·Milena KordalewskaDavid S Perlin

❮ Previous
Next ❯

Citations

Dec 6, 2018·Acta Clinica Belgica·Klaas DewaeleKatrien Lagrou
Feb 19, 2019·Mycoses·Shabir A Lone, Aijaz Ahmad
Jun 22, 2019·The Journal of Antimicrobial Chemotherapy·Sebastian WursterDimitrios P Kontoyiannis
Jul 22, 2019·The Journal of Antimicrobial Chemotherapy·Shivaprakash M RudramurthyArunaloke Chakrabarti
Jul 25, 2019·Journal of Fungi·Daniel Z P Friedman, Ilan S Schwartz
Jun 7, 2019·Archives of Pathology & Laboratory Medicine·D Jane HataUNKNOWN College of American Pathologists Microbiology Committee
Oct 28, 2019·Current Topics in Medicinal Chemistry·Laura Nunes SilvaAndré Luis Souza Dos Santos
Jan 31, 2020·Journal of Clinical Microbiology·Brian L Wickes
Mar 1, 2020·Journal of Fungi·Ryan KeanGordon Ramage
Apr 3, 2020·Expert Review of Anti-infective Therapy·Arunaloke Chakrabarti, Shreya Singh
May 3, 2019·Critical Care : the Official Journal of the Critical Care Forum·Andrea CortegianiDavid Eyre
May 25, 2020·The Medical Journal of Australia·Leon J WorthMonica A Slavin
Jul 17, 2020·Journal of Paediatrics and Child Health·Jayasree ChandramatiSasidharan Ponthenkandath
Jul 10, 2020·Pathogens and Disease·Taissa VilaMary Ann Jabra-Rizk
Aug 20, 2019·Internal Medicine Journal·Chong W OngUNKNOWN Australian and New Zealand Mycoses Interest Group (ANZMIG); and the Healthcare Infection Control Special Interest Group (HIC
Dec 19, 2019·Frontiers in Microbiology·Farid ChaabaneAlix T Coste
May 1, 2020·Frontiers in Genetics·Aleksandra D ChybowskaRhys A Farrer
Jul 9, 2020·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Eduardo Álvarez Duarte, Valentina Salas
Jul 14, 2020·Medical Mycology·Archana ThakreS Mohan Karuppayil
Sep 3, 2020·Antibiotics·Juan V Mulet BayonaConcepción Gimeno Cardona
Apr 21, 2020·Emerging Infectious Diseases·Kellie ArensmanJennifer Dela Pena
Sep 6, 2020·Antibiotics·María Guadalupe Frías-De-LeónErick Martínez-Herrera
Jul 25, 2019·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Angeliki StathiLevantia Zachariadou
Nov 7, 2018·Journal of Intensive Care·Andrea CortegianiAnuradha Chowdhary
Oct 23, 2020·PLoS Pathogens·Han DuGuanghua Huang
Nov 26, 2020·Journal of Fungi·Wadha AlfouzanMohammad R Al-Rashidi
Dec 10, 2020·Scientific Reports·Patrick SchwarzEric Dannaoui
Nov 20, 2020·Journal of Clinical Microbiology·Sourav DasAnup Ghosh
Sep 4, 2020·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Majid M AlshamraniHanan H Balkhy

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
chemical treatment
lavage
amputation
biopsy
electrophoresis

Software Mentioned

Excel
Flex Analysis
GraphPad Prism
ClinProTools
Vitek
GraphPad

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Shawn R LockhartAnastasia P Litvintseva
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Sharon TsaySnigdha Vallabhaneni
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
David Sears, Brian S Schwartz
The Journal of Antimicrobial Chemotherapy
Steve HernandezJohn R Graybill
© 2021 Meta ULC. All rights reserved